help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Online Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HUNT, J. F.
Right arrow Articles by GASTON, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HUNT, J. F.
Right arrow Articles by GASTON, B.
Am. J. Respir. Crit. Care Med., Volume 165, Number 1, January 2002, 101-107

Expression and Activity of pH-regulatory Glutaminase in the Human Airway Epithelium

JOHN F. HUNT, ELIZABETH ERWIN, LISA PALMER, JOHN VAUGHAN, NEIL MALHOTRA, THOMAS A. E. PLATTS-MILLS, and BENJAMIN GASTON

Division of Pediatric Respiratory Medicine and Division of Allergy, Asthma and Immunology, The University of Virginia Health System, Charlottesville, Virginia


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Fluid condensed from the breath of patients with acute asthma is acidic. Several features of asthma pathophysiology can be initiated by exposure of the airway to acid. In renal tubular epithelium, glutaminase produces ammonia to buffer urinary acid excretion. We hypothesized that human airway epithelium could also express glutaminase. Here, we demonstrate that human airway epithelial cells in vitro have biochemical evidence for glutaminase activity and express mRNA for two glutaminase isoforms (KGA and GAC). Glutaminase activity increased in response to acidic stress (media pH 5.8) and was associated with both increased culture medium pH and improved cell survival. In contrast, activity was inhibited by interferon-gamma and tumor necrosis factor-alpha . Glutaminase protein was expressed in the human airway in vivo. Further, ammonia levels in the breath condensate of subjects with acute asthma were low (30 µM [range: 0-233], n = 18, age 23 ± 2.5 yr) compared with control subjects (327 µM [14-1,220], n = 24, age 24 ± 2.4 yr, p < 0.001), and correlated with condensate pH (r = 0.58, p < 0.001). These data demonstrate that glutaminase is expressed and active in the human airway epithelium and may be relevant both to the regulation of airway pH and to the pathophysiology of acute asthmatic airway inflammation.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Keywords: asthma; glutaminase; ammonia; lung; breath condensate

Several features of asthma-including cough, epithelial cell damage, eosinophil necrosis, impaired ciliary motility, abnormal mucous production, and increased nitric oxide generation-may be initiated by exogenous exposure of the airway epithelium to acid in vitro and in vivo (1). We have recently reported that the pH of the exhaled water of patients during acute exacerbations of asthma is over two log orders lower than that of control subjects (3), raising the possibility that endogenous airway acids could contribute to asthma pathophysiology. Several cellular and inorganic processes may form and release acids in the airway, particularly in the setting of inflammation (6). However, the mechanisms by which this acid is buffered to maintain airway pH homeostasis are incompletely characterized.

The proximal renal tubule responds to an acid load by upregulation of the kidney isoform of glutaminase (KGA), an enzyme that buffers urinary acid by net formation of the base, ammonia* (pKa = 9.3) from glutamine (10, 11). A splice-variant isoform of glutaminase, termed GAC, has been identified in human lung homogenates (12), but the cellular source is not known. We hypothesized that glutaminase may be expressed in the airway epithelium and have a role in pH homeostasis. To test this hypothesis, we studied the expression and activity of glutaminase both in human airway epithelial cells in culture and in humans with and without asthma. Here, we report that (1) glutaminase is transcribed in normal human bronchial epithelial cells (NHBE), small airway epithelial cells (SAEC), and the Type II alveolar cell line A549; (2) airway epithelial cells produce ammonia stoichiometrically from glutamine; (3) these cells respond to acidic challenge by increasing production of ammonia, which neutralizes acid and enhances survival; (4) interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha inhibit this epithelial ammonia production; (5) patients with acute exacerbations of asthma have substantially less ammonia in their exhaled breath condensates than do control subjects; and (6) glutaminase protein is expressed in the human airway epithelium in vivo, and expression may be decreased in asthma. Because acidification and ammonia deprivation have antimicrobial effects (13, 14), we speculate that inhibition of glutaminase in the airway epithelium may be an important lung defense mechanism. In subjects with asthma, however, this mechanism may contribute to the pathophysiology of airway injury.

    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Human Airway Epithelial Cell Culture

A549 (ATCC, Manassas, VA), normal human bronchial epithelial cells (NHBE, Clonetics, Walkersville, MD), and small airway epithelial cells (SAEC, Clonetics) were incubated in bicarbonate-buffered Ham's F12K or bicarbonate-free CMRL media or in modified bicarbonate-buffered glutamine-controlled SAGM medium (Clonetics) and studied at confluence prior to third passage. Selected wells were incubated with TNF-alpha and IFN-gamma (100 units/ml each) and/or the glutaminase competitive antagonist 5-diazo-6-oxo-L-norleucine (DON, 2-4 mM) at various pH values and concentrations of glutamine or glutamate (0.5-10 mM). Assays of cell viability were performed by direct addition of Trypan Blue to cell wells.

Chemical Methods

Unless otherwise noted, reagents were obtained from Sigma (St. Louis, MO). Ammonia concentration was determined spectrophotometrically (15). pH was measured with a Corning microelectrode (Corning, NY) attached to an Orion 520A pH Meter (Orion, Beverly, MA). Deaeration/decarbonation of breath condensate specimens was achieved by bubbling with argon (350 ml/min) as previously reported (3).

Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) for Glutaminase mRNA

Total RNA was isolated from cells following the RNeasy protocol (Qiagen, Valencia, CA). Aliquots were mixed with KGA- or GAC-specific nested primers constructed according to Elgadi and coworkers (12). The PCR products were analyzed by gel electrophoresis.

Immunohistochemistry

Formalin-fixed sections (3-5 µm) from open lung biopsy specimens were blocked and incubated (4° C) with rabbit polyclonal antibody to rat glutaminase (graciously supplied by Dr. Norman P. Curthoys, Department of Biochemistry, Colorado State University) (16). Glutaminase isoforms are highly conserved between rat and human (12), and the specificity of this antibody had been previously described (17). After washing, sections were incubated with or without goat anti-rabbit biotinylated secondary antibody, followed by incubation with avidin-biotinylated horseradish peroxidase macromolecular complex solution. Glutaminase staining was visualized using 3,3'-diaminobenzidine substrate (Sigma).

Precipitation of Exhaled Breath Fluid

Nonsmoking, otherwise healthy human subjects with acute exacerbations of asthma were recruited from the clinics and inpatient wards. Subjects performed quiet tidal breathing for 5 min, exhaling into a plastic RTube disposable breath condensation collection device (Respiratory Research, Inc., Charlottesville, VA). Approximately 1 ml of fluid was collected during the procedure. Collected samples were frozen at -4 to -20° C. This study was reviewed and approved by the institutional human investigation committee, and patients provided informed consent.

Western Blotting

Proteins collected from epithelial cell lysates were separated by SDS- PAGE, transferred to a nitrocellulose membrane, and probed with rabbit polyclonal anti-rat glutaminase antibody. Glutaminase was visualized after addition of horseradish peroxidase-conjugated goat anti-rabbit antibody with subsequent enhanced chemiluminescence (Amersham).

Statistics

Data are presented as median and range or, if parametrically distributed, as arithmetic or geometric (pH) mean ± standard error of the mean. Differences between subjects with asthma and control subjects and the subgroups of treated incubated cells were analyzed by repeated measures ANOVA or ANOVA on ranks with appropriate pairwise comparisons (18). Differences were considered significant at p values < 0.05.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Airway Epithelial Cells Transcribe Message for Two Isoforms of Glutaminase

RT-PCR was performed using two sets of nested primers for GAC and KGA on RNA isolated from NHBE, SAEC, and A549 cells. Agarose gel electrophoresis of the resulting cDNA product revealed the presence of appropriately located bands at 480 bp (both the GAC and nested KGA cDNA product), 640 bp (KGA), and 260 bp (GAC nested) (Figure 1). Nonspecific bands were not detected.


View larger version (141K):
[in this window]
[in a new window]
 
Figure 1.   Airway epithelial cells transcribe glutaminase message. NHBE cells were harvested and RNA isolated. RT-PCR was performed using two sets of nested primers for GAC and KGA. The band at 680 (Lane 5) represents the cDNA product of KGA-specific primers. Bands at 464 are the RT-PCR product of nested KGA primers (Lane 3), and separately, GAC primers (Lane 4). Nested primers for GAC yielded the expected 248-bp product (Lane 2). Nonspecific bands were not detected. There was no evidence of DNA contamination of isolated RNA, as evidenced by lack of any bands in one lane (Lane 7) with primers but no reverse transcriptase. Lane 1 is a 100-bp DNA ladder. Lane 6 is the RT-PCR product of GAPDH-specific primers. Data are representative of three independent experiments and are identical with results from SAEC cells and A549 cells.

Airway Epithelial Cells in Vitro Convert Glutamine to Ammonia

All epithelial cell lines (A549, NHBE, and SAEC) produced ammonia stoichiometrically from glutamine (Figure 2A-2C). Addition of the glutaminase antagonist DON caused a pronounced decrease in ammonia production (p < 0.001, n = 3) in all three cell types. Similarly, replacement of glutamine with glutamate caused a prominent decrease in ammoniagenesis (Figure 2D). In contrast, medium without cells (n = 5, each medium type, each glutamine concentration) produced very low levels of ammonia from spontaneous decomposition of glutamine (data not shown).


View larger version (31K):
[in this window]
[in a new window]
 
Figure 2.   Ammoniagenesis by airway epithelial cells is dependent on glutamine availability. Confluent A549 cells (A) in Ham's F12K medium, (B) in bicarbonate-free CMRL medium, and (C ) SAEC cells and NHBE cells (not shown) in modified SAGM medium in six-well culture plates were incubated with various concentrations of glutamine at initial pH of 7.8-8.0. Supernatants were assayed every 24 h for ammonia. Glutamine-dependent ammonia production was evident in all cell lines. (D) Addition of 4 mM of the glutaminase competitive antagonist DON resulted in 42% reduction of A549 ammonia production when incubated with 4 mM glutamine (p < 0.001). Replacement of GLN with glutamate prevented ammonia production. Addition of 3 mM DON resulted in a prominent decrease of ammonia production in NHBE and SAEC cells incubated with 3 mM glutamine (data not shown). Control medium without cells produced only trace amounts of ammonia. Results presented are means of three to six concurrent experiments for each cell type, and are representative of multiple separate experiments. Data are presented as mean ± SE. Except time 0, all data points plotted represent significantly different means.

Glutaminase Expression Is Upregulated by Acidic Media

A549 cells incubated in CMRL media supplemented with 3 mM glutamine and challenged with initial pH 5.6 revealed 25-96% increased levels of glutaminase proteins compared with control cells incubated at normal pH, as quantified by densitometry after Western blot with rabbit anti-rat glutaminase antiserum (Figure 3). Three bands were visualized-consistent with the results of previous investigators revealing limited proteolytic digestion of two splice variant isoforms of glutaminase found in the lung.


View larger version (54K):
[in this window]
[in a new window]
 
Figure 3.   Glutaminase protein is enhanced by low pH media. Western blotting for glutaminase reveals approximately 25-96% increase in glutaminase after > 48 h in cells treated with initial media at pH 5.6 compared with normally treated cells. The three bands represent partial proteolytic digests of two isoforms of glutaminase (KGA and GAC). Lane 1 represents an equal amount of protein from homogenized rat kidney, revealing the rat KGA isoform.

Ammonia Production by Airway Epithelial Cells in Vitro Is Upregulated by Acidic Stress, Neutralizes Acidic Cell Culture Media, and Enhances Cell Survival

A549 cells in bicarbonate-free CMRL medium at initial pH values of 5.8 were supplemented with 0, 4, and 10 mM glutamine; pH and ammonia production were monitored for 72 h. Control wells without cells produced minimal ammonia, with no change in pH. The medium supernatant from cells incubated at initially acidic pH was partially or completely neutralized depending on the initial concentration of glutamine and resultant ammonia production (n = 3, p < 0.01) (Figure 4A). In general, cells survived poorly at low pH, with cell death evidenced by both inability to exclude trypan blue and sloughing of the cells from the plating surface. However, the cells in some wells incubated at low pH responded to the stress by a pronounced upregulation of ammonia production (n = 3 replicates of two independent experiments, p < 0.001 compared with normal pH) (Figure 4B) and concomitant neutralization of pH (p < 0.01) (Figure 4C). The cell populations that were able to accomplish this upregulation also had enhanced survival at 72 h (97 ± 0.33%)-similar to control wells at neutral pH (97 ± 0.6%)-when compared with nonresponding cells (51 ± 2.4%; p < 0.001) (Figure 4D).


View larger version (25K):
[in this window]
[in a new window]
 
Figure 4.   Ammonia production alkalinizes cell medium supernatant. A549 cells were incubated in a CO2-free atmosphere in bicarbonate-free CMRL medium supplemented with 0, 4, or 10 mM glutamine at initial pH of 5.8. Control wells without cells produced minimal ammonia, without pH alteration over time (not shown). (A) The medium of cells incubated initially at pH 5.8 gradually neutralized, with rate controlled by availability of glutamine. (B) During some experiments, acid-stressed cells responded with an accelerated increase in ammonia production (n = 6 responding wells, 6 non- responders) that resulted in (C ) more rapid neutralization of pH and (D) enhanced survival when compared with non-responders (p < 0.01).

Similar experiments were performed in 20 mM bicarbonate-containing Ham's F12K medium. This media required preincubation and pH adjustment in a 5% CO2 atmosphere before use. In the absence of cells, bicarbonate-buffered medium acidified with HCl to pH 5.4 spontaneously increased pH (pH = 6.46 ± 0 at 48 h) while producing minimal ammonia (< 150 µM). The presence of A549 cells in medium at initial pH 5.4 greatly augmented both ammonia production at 48 h (2,747 ± 43 µM, p < 0.001 compared with medium, n = 3) and speed of neutralization of pH (7.5 ± 0.03 at 48 h; p < 0.001). In comparison, cells treated initially with pH 7.8 produced much less ammonia (1,585 ± 50 µM; p < 0.001 compared with pH 5.4 treated cells, n = 3) while alkalinizing the media more modestly (pH = 8.5 ± 0.0 at 48 h; n = 3). The ability to further alkalinize medium starting from above neutral is present only with the bicarbonate-buffered medium consistent with the hypothesized roles of HCO3- and ammonia in airway epithelial pH control.

Glutaminase Activity in Airway Epithelial Cells Is Downregulated by IFN-gamma and TNF-alpha

SAEC cells at confluence in six-well culture clusters in SAGM media (pH 7.5) supplemented with 3 mM glutamine were treated with 100 units/ml of IFN-gamma and 100 units/ml of TNF-alpha . Ammonia production by cytokine-treated cells was significantly less than that by untreated controls at 24, 48, and 72 h. For example, at 48 h, treated cells produced 371 ± 52 nmol of ammonia compared with control cells that produced 846 ± 49 nmols (n = 3 replicates each; p < 0.001) (Figure 5).


View larger version (18K):
[in this window]
[in a new window]
 
Figure 5.   IFN-gamma and TNF-alpha downregulate ammonia production in vitro. SAEC cells were grown in supplemented SAGM medium with 3 mM GLN in the presence and absence of 100 units/ml of both IFN-gamma and TNF-alpha . Cytokines significantly decreased SAEC ammonia production at all time points (n = 3 each, p < 0.001).

Ammonia Levels Are Low in Fluid Condensed from the Expired Air of Subjects with Acute Exacerbations of Asthma

Exhaled breath condensate was collected from 32 human subjects, and ammonia was assayed as noted in METHODS. Median breath condensate ammonia concentration was 10-fold lower in specimens from acutely ill subjects with asthma (30 µM [range: 0-233], n = 18, age 23 ± 2.5 yr) than from control subjects (327 µM [14-1,220], n = 24, age 24 ± 2.4 yr, p < 0.001) with a positive logarithmic relationship to same sample pH measurements (r = 0.58, p < 0.001) (Figure 6A).


View larger version (12K):
[in this window]
[in a new window]
 


View larger version (16K):
[in this window]
[in a new window]
 
Figure 6.   Ammonia concentration in exhaled breath condensate of patients with acute asthma is low. Exhaled breath condensate was collected from patients admitted to the hospital or seen in the emergency department with acute exacerbations of asthma or from healthy volunteers. (A) The median ammonia concentration in subjects with asthma (30; range, 0-233; n = 18, age 23 ± 2.5 yr) was 10-fold lower than in control subjects (327; range, 14-1220; age 24 ± 2.4 yr) by Mann-Whitney rank-sum testing (p < 0.001). (B) Ammonia concentrations were correlated with logarithmically transformed H+ concentrations (pH) (r = 0.55; p < 0.001). Though loss of ammonia production is permissive for acidification, it is clearly not the only determinant.

Immunohistochemistry

Open lung biopsy specimens from a subject with severe asthma (kindly provided by Dr. Serpil Erzurum) were compared with histologically normal lung tissue obtained from a steroid-naive subject without asthma and a subject who had been treated with systemic corticosteroids. Tissues were immunostained as described in METHODS. There was strong immunoreactivity for glutaminase in all specimens, particularly near the apical surface of the epithelium. Epithelial staining was dramatically less, however, in the asthmatic tissue. Primary and secondary antibodies alone revealed no staining in any specimen (Figure 7).


View larger version (130K):
[in this window]
[in a new window]
 
Figure 7.   Glutaminase protein is expressed in human airway epithelial cells and is upregulated by corticosteroids in vivo. Open lung biopsy specimens from a subject with a severe asthma exacerbation (A) (provided courtesy of Dr. S. Erzurum) are compared with those from a subject without asthma with a histologically normal lung (B) and a subject without asthma treated with systemic corticosteroids (C ). There was more glutaminase immunoreactivity (brown) in the airway epithelium of the control subject (B) than of the subject with asthma (A). Glutaminase staining is further enhanced in the corticosteroid-treated patient (C ). (D) The secondary antibody in the absence of primary antibody had no reactivity; the same was true using primary antibody and no secondary antibody for all tissues (not shown).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Substantial lung injury may result from exposure of the airway to exogenous acid (1, 2, 4, 19), in part because the cytotoxicity of oxygen radicals and nitrogen oxides produced in the airway is dramatically enhanced by protonation (23, 24). Efforts to characterize the mechanisms by which the airway protects itself from acid have focused primarily on the role of ion channels and luminal albumin (25). Recent evidence that endogenous airway acidification may also contribute to the pathophysiology of cystic fibrosis (26) and asthma (3) has led to renewed interest in the regulation of airway pH. However, it has not previously been considered that ammonia production by the airway epithelium could have a role in this process. Here, we demonstrate that the human airway epithelium-like the renal tubular epithelium-neutralizes acid by converting glutamine to ammonia and expresses glutaminase in vitro and in vivo (Figure 8). These novel observations may have implications for the management of infectious and inflammatory lung diseases.


View larger version (11K):
[in this window]
[in a new window]
 
Figure 8.   Model of airway epithelial ammonia production and lining fluid proton buffering. Glutamine is imported into the cell where it is catabolized by glutaminase to release ammonia, glutamate, and a proton. Ammonia diffuses across the luminal membrane to react with available protons, and then is exhaled or pumped back into the epithelium. The proton generated can be exported basolaterally or be consumed in other cellular processes. OONO, peroxynitrite; NO2-, nitrite; NH3, ammonia; NH4+, ammonium.

Ammonia is a highly water-soluble base (pKa of 9.4) found in gas phase in the exhaled breath and alveolar air of normal subjects (28). It is believed to have a role in neutralizing exogenous acids in air pollution (29) and can be formed by pharyngeal bacteria. Our findings demonstrate that it is also produced directly by airway epithelial cells and can buffer both endogenous and exogenous acids (Figures 4 and 6B). Indeed, we find that airway epithelial cells-like renal tubular epithelial cells (10, 11, 30)-are capable of upregulating their ammonia production in vitro in response to acid challenge (Figure 4), and that this ammonia serves to alkalinize pH. Even in the presence of high concentrations of HCO3- in Ham's F12K media (20 mM compared with airway lining fluid levels of < 6 mM [31]), the presence of epithelial cells strongly augmented the neutralization of pH concurrent with ammonia production. Importantly, glutaminase produces ammonia, glutamate, and a proton (H+) in the renal epithelium. The H+ may be pumped basolaterally by ion exchange. However, because airway epithelial cells neutralize acid in vitro without basolateral exchange, we speculate that subsequent metabolism of glutamate to HCO3- is important in determining the ultimate fate of luminal acid. Additional studies will be required to determine the relative importance of H+ and HCO3- exchange mechanisms-and of glutamate metabolism-to the glutaminase pathway in the airway epithelium in vivo.

During acute exacerbations of asthma, exhaled breath condensate ammonia concentrations are low when pH is low (Figure 6) and airway glutaminase expression may be decreased (Figure 7). Although cause and effect cannot be established unequivocally, these observations-in association with the in vitro data presented-suggest that inhibition of glutaminase expression may contribute to the low breath condensate pH observed in acute asthma (3). Intriguingly, the biochemical and cellular toxicities that result from exposure of airway epithelium to acid reflect the pathophysiological features of asthma to a striking degree. These toxicities include augmented release of eosinophil inflammatory mediators (23, 32), enhanced reactivity of nitrogen and oxygen species (3, 24, 33), decreased ciliary beating (4), increased mucous viscosity (19), epithelial dysfunction and sloughing (2, 20), and augmentation of neurogenic bronchoconstriction and cough (1, 21). The apparent association between impaired ammonia production and asthmatic airway inflammation raises the possibility that interventions that improve buffering of airway pH-including those that increase the expression of airway epithelial glutaminase-may be helpful in preventing and treating exacerbations of asthma.

The acid burden delivered to the airway lumen may be substantial. In addition to serving as the site for excretion of carbon dioxide/carbonic acid, the distal airways and alveoli are also exposed to H+ release from Type II alveolar cells because of vacuolar (V) H+-ATPase activity in lamellar bodies (8). Inflammatory cells such as macrophages and eosinophils also have VATPases in their vesicles (34); chronic inflammation with necrosis of these cells can result in marked airway acidification analogous to that in infected pleural space (35). These and other processes potentially may be buffered in the airway by luminal albumin and, as in the kidney, by HCO3- excretion, Na+/H+ exchange and carbonic anhydrase. However, we suggest that a substantial quantity of titratable acid formed in the lung may react with ammonia. The relevance of ammonia to airway pH homeostasis is suggested by the observations that (1) exposure of airway epithelial cells to physiological concentrations of glutamine (36) results in the production of stoichiometric millimolar concentrations of ammonia (Figure 2); (2) low breath condensate pH is associated with low breath condensate ammonia in vivo (Figure 6); and (3) despite the presence of albumin, bicarbonate, and other buffers in the cell culture medium, airway epithelial cell ammonia production robustly alkalinized pH in vitro (Figure 4A-4C).

Figure 6B suggests that ammonia depletion may be necessary, but not exclusively sufficient, for acidification: breath with low ammonia content can have a neutral pH. The presence of multiple buffering systems appears to be particularly important to airway epithelial cells, which tolerate low pH poorly if they fail to increase ammonia production markedly above control levels (Figure 4D). Indeed, cells that did not respond with increased ammonia production demonstrated sloughing from the culture plate analogous to airway epithelial sloughing observed during asthma exacerbations in vivo (37, 38). The factors that regulate this ammonia-based protective response to low pH remain to be clarified, but may be critically relevant to airway inflammation and are the subject of ongoing investigation. It should be noted that there may be several sources of ammonia in the airway. We found that epithelial cell lines derived from the proximal airway, small airways, and alveoli had glutaminase mRNA activity. The extrathoracic airway may also contribute to ammonia production, especially given the role of glutaminase activity in immune cells and the potential for ammonia production by bacteria (39, 40).

Our data suggest that one mechanism involved in the inhibition of pulmonary ammonia excretion in acute asthma may involve exposure of the airway epithelium to inflammatory cytokines. Sarantos and coworkers have shown that glutaminase activity is downregulated by T helper 1-type lymphocyte (Th1)-derived cytokines in a fibroblast cell line (41), and we have confirmed this finding in airway epithelial cell lines (Figure 5). In this regard, it is increasingly appreciated that Th1 cytokines (such as those produced in response to infection with rhinovirus) may help to initiate "common-cold"-associated exacerbations of asthma in the allergen-primed, inflammatory cell-rich asthmatic lung (42, 43). These same cytokines are released in response to Mycobacterium tuberculosis-an organism that requires exogenous ammonia (14, 44), and is intolerant of acidic conditions (13, 45). It is tempting to speculate that the asthmatic phenotype-in which airway ammonia production is decreased and pH falls-may limit substrate for ammonia-requiring M. tuberculosis while providing an inhospitable acidic environment. This process could be detrimental, however, in the allergen-exposed, eosinophil-infiltrated lung.

In conclusion, we have shown that glutaminase is expressed and active in the human airway epithelium and production of ammonia by airway epithelial cells serves a pH homeostatic role-increasing protectively in response to acidic stress-and is inhibited by inflammatory cytokines. Direct relevance of this pathway to human disease is suggested by the permissive effect of ammonia depletion on exhaled airway fluid acidification during asthma exacerbations. These observations may have broad implications for the management of infectious and inflammatory lung diseases.

    Footnotes

Correspondence and requests for reprints should be addressed to Benjamin Gaston, M.D., Department of Pediatrics, Box 386, The University of Virginia Health System, Charlottesville, VA 22908. E-mail: bmg3g{at}virginia.edu

(Received in original form April 27, 2001 and accepted in revised form August 27, 2001).

This article has an online data supplement, which is accessible from this issue's table of contents online at www.atsjournals.org.
* We will refer to ammonia (NH3) and ammonium (NH4+)-which exist in equilibrium in solution-as "ammonia," except where we are referring exclusively to the protonated species. Both are measured simultaneously in our assay system.

Acknowledgments: The authors wish to acknowledge the assistance of Alisa Smith and Daniel Chernavvsky for their expert technical advice, Serpil Erzurum for kindly providing biopsy tissues, and Norman Curthoys for generously providing antiglutaminase antibody.

Supported by the American Academy of Allergy and Immunology Education and Research Trust (J.H.), GlaxoSmithKline (J.H., E.E.), The Virginia Thoracic Society (J.H.), Henry B. Wallace Foundation (B.G.), NIH RO1 HL59337 (B.G.), NIH Asthma Center Grant 1U19-A134607 (B.G., T.A.E.P.M.), and the University of Virginia Children's Medical Center. J.H. is a Parker B. Francis Fellow in Pulmonary Research.

    References
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1. Bevan S, Geppetti P. Protons: small stimulants of capsaicin-sensitive sensory nerves. Trends Neurosci 1994; 17: 509-512 [Medline].

2. Holma B, Lindegren M, Andersen JM. pH effects on ciliomotility and morphology of respiratory mucosa. Arch Environ Health 1977; 32: 216-226 [Medline].

3. Hunt JF, Fang K, Malik R, Snyder A, Malhotra N, Platts-Mills TA, Gaston B. Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 2000;161(3, Pt 1):694-699.

4. Luk CK, Dulfano MJ. Effect of pH, viscosity and ionic-strength changes on ciliary beating frequency of human bronchial explants. Clin Sci 1983; 64: 449-451 [Medline].

5. Holma B. Influence of buffer capacity and pH-dependent rheological properties of respiratory mucus on health effects due to acidic pollution. Sci Total Environ 1985; 41: 101-123 [Medline].

6. Acevedo M, Steele LW. Na(+)-H+ exchanger in isolated epithelial tracheal cells from sheep. Involvement in tracheal proton secretion. Exp Physiol 1993; 78: 383-394 [Abstract].

7. Pacheco G, Lippo de Becemberg I, Gonzalez de Alfonzo R, Alfonzo MJ. Biochemical characterization of a V-ATPase of tracheal smooth muscle plasma membrane fraction. Biochim Biophys Acta 1996; 1282: 182-192 [Medline].

8. Wadsworth SJ, Spitzer AR, Chander A. Ionic regulation of proton chemical (pH) and electrical gradients in lung lamellar bodies. Am J Physiol 1997;273(2, Pt 1):L427-L436.

9. Swenson ER, Robertson HT, Hlastala MP. Effects of carbonic anhydrase inhibition on ventilation-perfusion matching in the dog lung. J Clin Invest 1993; 92: 702-709 .

10. Welbourne TC, Phromphetcharat V. Renal glutamine metabolism and hydrogen ion homeostasis. In: Haussinger D, Sies H, editors. Glutamine metabolism in mammalian tissues. New York: Springer-Verlag; 1984. p. 161-177.

11. Laterza OF, Hansen WR, Taylor L, Curthoys NP. Identification of an mRNA-binding protein and the specific elements that may mediate the pH-responsive induction of renal glutaminase mRNA. J Biol Chem 1997; 272: 22481-22488 [Abstract/Free Full Text].

12. Elgadi KM, Meguid RA, Qian M, Souba WW, Abcouwer SF. Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing. Physiol Genom 1999; 1: 51-62 .

13. Piddington DL, Kashkouli A, Buchmeier NA. Growth of Mycobacterium tuberculosis in a defined medium is very restricted by acid pH and Mg(2+) levels. Infect Immun 2000; 68: 4518-4522 [Abstract/Free Full Text].

14. Gordon AH, Hart PD, Young MR. Ammonia inhibits phagosome-lysosome fusion in macrophages. Nature 1980; 286: 79-80 [Medline].

15. Neeley WE, Phillipson J. Automated enxymatic method for determining ammonia in plasma with 14 day reagent stability. Clin Chem 1968; 34: 1868 [Abstract/Free Full Text].

16. Newcomb R, Pierce AR, Kano T, Meng W, Bosque-Hamilton P, Taylor L, Curthoys N, Lo EH. Characterization of mitochondrial glutaminase and amino acids at prolonged times after experimental focal cerebral ischemia. Brain Res 1998; 813: 103-111 [Medline].

17. Cangro CB, Sweetnam PM, Wrathall JR, Haser WB, Curthoys NP, Neale JH. Localization of elevated glutaminase immunoreactivity in small DRG neurons. Brain Res 1985; 336: 158-161 [Medline].

18. Lindsey JK. Models for Repeated Measurements. Oxford: Clarendon Press; 1990.

19. Holma B, Hegg PO. pH- and protein-dependent buffer capacity and viscosity of respiratory mucus. Their interrelationships and influence on health. Sci Total Environ 1989; 84: 71-82 [Medline].

20. Riechelmann H, Maurer J, Kienast K, Hafner B, Mann WJ. Respiratory epithelium exposed to sulfur dioxide-functional and ultrastructural alterations. Laryngoscope 1995;105(3, Pt 1):295-299.

21. Ricciardolo FLM, Rado V, Fabbri LM, Sterk PJ, Di Maria GU, Geppetti P. Bronchoconstriction induced by citric acid inhalation in guinea pigs: role of tachykinins, bradykinin, and nitric oxide. Am J Respir Crit Care Med 1999; 159: 557-562 [Abstract/Free Full Text].

22. Jack CI, Calverley PM, Donnelly RJ, Tran J, Russell G, Hind CR, Evans CC. Simultaneous tracheal and oesophageal pH measurements in asthmatic patients with gastro-oesophageal reflux. Thorax 1995; 50: 201-204 [Abstract].

23. Hunt J, Fang K, Platts-Mills T, Gaston B. Nitrogen oxide redox balance in asthma [abstract]. Am J Respir Crit Care Med 1999; 159: A860 .

24. Crow JP, Spruell C, Chen J, Gunn C, Ischiropoulos H, Tsai M, Smith CD, Radi R, Koppenol WH, Beckman JS. On the pH-dependent yield of hydroxyl radical products from peroxynitrite. Free Radic Biol Med 1994; 16: 331-338 [Medline].

25. Kyle H, Ward JP, Widdicombe JG. Control of pH of airway surface liquid of the ferret trachea in vitro. J Appl Physiol 1990; 68: 135-140 [Abstract/Free Full Text].

26. Smith JJ, Welsh MJ. cAMP stimulates bicarbonate secretion across normal, but not cystic fibrosis airway epithelia. J Clin Invest 1992; 89: 1148-1153 .

27. Robinson NP, Kyle H, Webber SE, Widdicombe JG. Electrolyte and other chemical concentrations in tracheal airway surface liquid and mucus. J Appl Physiol 1989; 66: 2129-2135 [Abstract/Free Full Text].

28. Spanel P, Davies S, Smith D. Quantification of ammonia in human breath by the selected ion flow tube analytical method using H30+ and 02+ precursor ions. Rapid Commun Mass Spectrom 1998; 12: 763-766 [Medline].

29. Larson TV, Covert DS, Frank R, Charlson RJ. Ammonia in the human airways: neutralization of inspired acid sulfate aerosols. Science 1977; 197: 161-163 [Abstract/Free Full Text].

30. Curthoys NP, Watford M. Regulation of glutaminase activity and glutamine metabolism. Annu Rev Nutr 1995; 15: 133-159 [Medline].

31. Govindaraju K, Cowley EA, Eidelman DH, Lloyd DK. Microanalysis of lung airway surface fluid by capillary electrophoresis with conductivity detection. Anal Chem 1997; 69: 2793-2797 [Medline].

32. Walsh GM. Human eosinophils: their accumulation, activation and fate. Br J Haematol 1997; 97: 701-709 [Medline].

33. Gaston B, Stamler JS. Nitrogen Oxides. In: Crystal RG, editor. The lung: Scientific foundations, 2nd ed. Philadelphia: Lippincott-Raven; 1997. p. 239-253.

34. Kurashima K, Numata M, Yachie A, Sai Y, Ishizaka N, Fujimura M, Matsuda T, Ohkuma S. The role of vacuolar H(+)-ATPase in the control of intragranular pH and exocytosis in eosinophils. Lab Invest 1996; 75: 689-698 [Medline].

35. Chavalittamrong B, Angsusingha K, Tuchinda M, Habanananda S, Pidatcha P, Tuchinda C. Diagnostic significance of pH, lactic acid dehydrogenase, lactate and glucose in pleural fluid. Respiration 1979; 38: 112-120 [Medline].

36. Hack V, Weiss C, Friedmann B, Suttner S, Schykowski M, Erbe N, Benner A, Bartsch P, Droge W. Decreased plasma glutamine level and CD4+ T cell number in response to 8 wk of anaerobic training. Am J Physiol 1997;272(5, Pt 1):E788-E795.

37. Pin I, Godard P. [Mechanisms of bronchial hyperreactivity: role of airway inflammation and atopy]. Rev Mal Respir 1994; 11: 111-122 [Medline].

38. Hogg JC. The pathology of asthma. Clin Chest Med 1984; 5: 567-571 [Medline].

39. Kew S, Wells SM, Yaqoob P, Wallace FA, Miles EA, Calder PC. Dietary glutamine enhances murine T-lymphocyte responsiveness. J Nutr 1999; 129: 1524-1531 [Abstract/Free Full Text].

40. Murphy C, Newsholme P. Importance of glutamine metabolism in murine macrophages and human monocytes to L-arginine biosynthesis and rates of nitrite or urea production. Clin Sci (Colch) 1998; 95: 397-407 [Medline].

41. Sarantos P, Abouhamze A, Abcouwer S, Chakrabarti R, Copeland EM, Souba WW. Cytokines decrease glutaminase expression in human fibroblasts. Surgery 1994;116:276-283; discussion 283-284.

42. Sethi SK, Bianco A, Allen JT, Knight RA, Spiteri MA. Interferon-gamma (IFN-gamma) down-regulates the rhinovirus-induced expression of intercellular adhesion molecule-1 (ICAM-1) on human airway epithelial cells. Clin Exp Immunol 1997; 110: 362-369 [Medline].

43. Wimalasundera SS, Katz DR, Chain BM. Characterization of the T cell response to human rhinovirus in children: implications for understanding the immunopathology of the common cold. J Infect Dis 1997; 176: 755-759 [Medline].

44. Harth G, Clemens DL, Horwitz MA. Glutamine synthetase of Mycobacterium tuberculosis: extracellular release and characterization of its enzymatic activity. Proc Natl Acad Sci USA 1994; 91: 9342-9346 [Abstract/Free Full Text].

45. Crowle AJ, Dahl R, Ross E, May MH. Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic. Infect Immun 1991; 59: 1823-1831 [Abstract/Free Full Text].





This article has been cited by other articles:


Home page
Eur Respir JHome page
A. O. Paget-Brown, J. F. Hunt, and B. Gaston
Tracheal aspirate pH is alkaline in pre-term human infants
Eur. Respir. J., November 1, 2007; 30(5): 840 - 842.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Kodric, A. N. Shah, L. M. Fabbri, and M. Confalonieri
An Investigation of Airway Acidification in Asthma Using Induced Sputum: A Study of Feasibility and Correlation
Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 905 - 910.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
H.-W. Shin, D. A. Shelley, E. M. Henderson, A. Fitzpatrick, B. Gaston, and S. C. George
Airway nitric oxide release is reduced after PBS inhalation in asthma
J Appl Physiol, March 1, 2007; 102(3): 1028 - 1033.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. M. Effros, R. Casaburi, J. Su, M. Dunning, J. Torday, J. Biller, and R. Shaker
The Effects of Volatile Salivary Acids and Bases on Exhaled Breath Condensate pH
Am. J. Respir. Crit. Care Med., February 15, 2006; 173(4): 386 - 392.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
ATS Workshop Proceedings: Exhaled Nitric Oxide and Nitric Oxide Oxidative Metabolism in Exhaled Breath Condensate.
Proceedings of the ATS, January 1, 2006; 3(2): 131 - 145.
[Full Text] [PDF]


Home page
Eur Respir JHome page
I. Horvath, J. Hunt, P. J. Barnes, and On behalf of the ATS/ERS Task Force on Exhaled Bre
Exhaled breath condensate: methodological recommendations and unresolved questions
Eur. Respir. J., September 1, 2005; 26(3): 523 - 548.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
G. MacGregor, S. Ellis, J. Andrews, M. Imrie, A. Innes, A. P. Greening, and S. Cunningham
Breath condensate ammonium is lower in children with chronic asthma
Eur. Respir. J., August 1, 2005; 26(2): 271 - 276.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J C Ojoo, S A Mulrennan, J A Kastelik, A H Morice, and A E Redington
Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis
Thorax, January 1, 2005; 60(1): 22 - 26.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
K Wells, J Vaughan, T N Pajewski, S Hom, L Ngamtrakulpanit, A Smith, A Nguyen, R Turner, and J Hunt
Exhaled breath condensate pH assays are not influenced by oral ammonia
Thorax, January 1, 2005; 60(1): 27 - 31.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. Corradi, P. Pignatti, P. Manini, R. Andreoli, M. Goldoni, M. Poppa, G. Moscato, B. Balbi, and A. Mutti
Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation
Eur. Respir. J., December 1, 2004; 24(6): 1011 - 1017.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. M. Effros, M. B. Dunning III, J. Biller, and R. Shaker
The promise and perils of exhaled breath condensates
Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1073 - L1080.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. L. M. Ricciardolo, P. J. Sterk, B. Gaston, and G. Folkerts
Nitric Oxide in Health and Disease of the Respiratory System
Physiol Rev, July 1, 2004; 84(3): 731 - 765.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
A Niimi, L T Nguyen, O Usmani, B Mann, and K F Chung
Reduced pH and chloride levels in exhaled breath condensate of patients with chronic cough
Thorax, July 1, 2004; 59(7): 608 - 612.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
R.M. Effros
Exhaled breath condensate pH
Eur. Respir. J., June 1, 2004; 23(6): 961 - 962.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Castell, C. Vance, R. Abbott, J. Marquez, and P. Eggleton
Granule Localization of Glutaminase in Human Neutrophils and the Consequence of Glutamine Utilization for Neutrophil Activity
J. Biol. Chem., April 2, 2004; 279(14): 13305 - 13310.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
D. A. Groneberg, A. Fischer, K. F. Chung, and H. Daniel
Molecular Mechanisms of Pulmonary Peptidomimetic Drug and Peptide Transport
Am. J. Respir. Cell Mol. Biol., March 1, 2004; 30(3): 251 - 260.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
H.-W. Shin, C. M. Rose-Gottron, D. M. Cooper, R. L. Newcomb, and S. C. George
Airway diffusing capacity of nitric oxide and steroid therapy in asthma
J Appl Physiol, January 1, 2004; 96(1): 65 - 75.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J. Vaughan, L. Ngamtrakulpanit, T.N. Pajewski, R. Turner, T-A. Nguyen, A. Smith, P. Urban, S. Hom, B. Gaston, and J. Hunt
Exhaled breath condensate pH is a robust and reproducible assay of airway acidity
Eur. Respir. J., December 1, 2003; 22(6): 889 - 894.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. M. Effros, B. Gaston, A. Mutti, and M. Corradi
Saving the Breath Condensate Approach
Am. J. Respir. Crit. Care Med., November 1, 2003; 168(9): 1129 - 1132.
[Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C. Wijkstrom-Frei, S. El-Chemaly, R. Ali-Rachedi, C. Gerson, M. A. Cobas, R. Forteza, M. Salathe, and G. E. Conner
Lactoperoxidase and Human Airway Host Defense
Am. J. Respir. Cell Mol. Biol., August 1, 2003; 29(2): 206 - 212.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. Baraldi, L. Ghiro, V. Piovan, S. Carraro, G. Ciabattoni, P. J. Barnes, and P. Montuschi
Increased Exhaled 8-Isoprostane in Childhood Asthma
Chest, July 1, 2003; 124(1): 25 - 31.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. Vass, E. Huszar, E. Barat, M. Valyon, D. Kiss, I. Penzes, M. Augusztinovicz, and I. Horvath
Comparison of Nasal and Oral Inhalation during Exhaled Breath Condensate Collection
Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 850 - 855.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. J. Albert, A. K. Thukkani, R. M. Heuertz, A. Slungaard, S. L. Hazen, and D. A. Ford